Grant: Doctoral Research Award: Canada Graduate Scholarships
Université Laval
$120,000.00
Blood-matrix triggered changes in the 3D structure and bioactivity of insulin
FY 2024-25
Summary
Insulin is a hormone secreted by the pancreas into the bloodstream. It controls how much sugar our body captures from the blood to use as energy. Lack of insulin action is associated with several diseases, including diabetes. The absence of insulin itself causes type 1 diabetes, whereas the body's inability to use insulin properly causes type 2 diabetes. Although insulin injections have been used as a treatment for type 1 diabetes for over 100 years to restore proper levels of insulin in the blood, the treatment of type 2 diabetes is more complicated. We still do not fully understand how the body becomes resistant to insulin in type 2 diabetes. My research project aims to fill this gap by studying the 3D structure of insulin and its interactions with other components of the blood that likely interfere with our capacity to use insulin.
It is widely accepted that insulin is found in the blood uniquely as monomers. These single molecules can activate the insulin receptor as soon as they reach the target organs, and insulin resistance occurs when these organs fail to recognize "active" insulin. Some evidence shows this is not the case. Insulin molecules can bind to each other to form groups of 2 (dimers) or 6 (hexamers) insulin molecules. These structures are abundant in the pancreas, where insulin is stored. The shape and properties of insulin make it much more stable in multimeric form than as single monomers. This suggests that insulin could circulate in the blood in this form but would be unable to activate a response in the target organ. Other molecules found in the blood can also interact with insulin. They could block its ability to activate the insulin receptor and to control blood sugar levels correctly. I will study the non-monomeric forms of insulin and investigate if their levels are higher in the blood of type 2 diabetic patients to see if this could explain insulin resistance.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
518543
Name
Boulay Gabriel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Blood-matrix triggered changes in the 3D structure and bioactivity of insulin
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
3d Structure Of Hormones; Analytical Assay Development And Validation; Clinical Utility; Crystallography; Double Elisa; Electron Microscopy; Insulin Resistance; Nuclear Magnetic Resonance; Protein Chemistry; Type 2 Diabetes
Abstract
Insulin is a hormone secreted by the pancreas into the bloodstream. It controls how much sugar our body captures from the blood to use as energy. Lack of insulin action is associated with several diseases, including diabetes. The absence of insulin itself causes type 1 diabetes, whereas the body's inability to use insulin properly causes type 2 diabetes. Although insulin injections have been used as a treatment for type 1 diabetes for over 100 years to restore proper levels of insulin in the blood, the treatment of type 2 diabetes is more complicated. We still do not fully understand how the body becomes resistant to insulin in type 2 diabetes. My research project aims to fill this gap by studying the 3D structure of insulin and its interactions with other components of the blood that likely interfere with our capacity to use insulin.
It is widely accepted that insulin is found in the blood uniquely as monomers. These single molecules can activate the insulin receptor as soon as they reach the target organs, and insulin resistance occurs when these organs fail to recognize "active" insulin. Some evidence shows this is not the case. Insulin molecules can bind to each other to form groups of 2 (dimers) or 6 (hexamers) insulin molecules. These structures are abundant in the pancreas, where insulin is stored. The shape and properties of insulin make it much more stable in multimeric form than as single monomers. This suggests that insulin could circulate in the blood in this form but would be unable to activate a response in the target organ. Other molecules found in the blood can also interact with insulin. They could block its ability to activate the insulin receptor and to control blood sugar levels correctly. I will study the non-monomeric forms of insulin and investigate if their levels are higher in the blood of type 2 diabetic patients to see if this could explain insulin resistance.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Boulay, Gabriel
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~